Tau Reduction Prevents Key Features of Autism in Mouse Models

[1]  K. Xia,et al.  Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice , 2019, Scientific Reports.

[2]  J. Dougherty,et al.  Erroneous inference based on a lack of preference within one group: autism, mice, and the Social Approach Task , 2019, bioRxiv.

[3]  S. Maeda,et al.  Neuronal levels and sequence of tau modulate the power of brain rhythms , 2018, Neurobiology of Disease.

[4]  Z. Warren,et al.  Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[5]  B. Chung,et al.  Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism , 2017, Molecular Autism.

[6]  L. Buée,et al.  Atypical, non-standard functions of the microtubule associated Tau protein , 2017, Acta neuropathologica communications.

[7]  T. Fath,et al.  Tau exacerbates excitotoxic brain damage in an animal model of stroke , 2017, Nature Communications.

[8]  Lewis C. Cantley,et al.  The PI3K Pathway in Human Disease , 2017, Cell.

[9]  L. Buée,et al.  Tau deletion promotes brain insulin resistance , 2017, The Journal of experimental medicine.

[10]  J. Morys,et al.  BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity , 2017, Cellular and Molecular Neurobiology.

[11]  W. Catterall.  Forty Years of Sodium Channels: Structure, Function, Pharmacology, and Epilepsy , 2017, Neurochemical Research.

[12]  A. Rodrigues,et al.  Tau-dependent suppression of adult neurogenesis in the stressed hippocampus , 2017, Molecular Psychiatry.

[13]  K. Vossel,et al.  Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture , 2017, Molecular Neurodegeneration.

[14]  G. Feng,et al.  SHANK proteins: roles at the synapse and in autism spectrum disorder , 2017, Nature Reviews Neuroscience.

[15]  John F. Cryan,et al.  Adult microbiota‐deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus , 2016, The European journal of neuroscience.

[16]  P. Crino.  The mTOR signalling cascade: paving new roads to cure neurological disease , 2016, Nature Reviews Neurology.

[17]  R. Schwarting,et al.  Early communication deficits in the Shank1 knockout mouse model for autism spectrum disorder: Developmental aspects and effects of social context , 2016, Autism research : official journal of the International Society for Autism Research.

[18]  G. Fishell,et al.  Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops , 2016, Neuron.

[19]  Jeffrey A. Porter,et al.  CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency , 2016, Science.

[20]  S. Maeda,et al.  Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice , 2016, EMBO reports.

[21]  Lilian Enriquez-Barreto,et al.  The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia , 2016, Molecular and Cellular Therapies.

[22]  Ann M. Graybiel,et al.  Neurobiology of rodent self-grooming and its value for translational neuroscience , 2015, Nature Reviews Neuroscience.

[23]  E. Mandelkow,et al.  Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.

[24]  Roberto Sacco,et al.  Head circumference and brain size in autism spectrum disorder: A systematic review and meta-analysis , 2015, Psychiatry Research: Neuroimaging.

[25]  D. Geschwind,et al.  Gene hunting in autism spectrum disorder: on the path to precision medicine , 2015, The Lancet Neurology.

[26]  J. Paul Leigh,et al.  Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States , 2015, Journal of autism and developmental disorders.

[27]  H. J. Schelhaas,et al.  Autism and behavior in adult patients with Dravet syndrome (DS) , 2015, Epilepsy & Behavior.

[28]  K. Vossel,et al.  JCB_201407065 1..15 , 2015 .

[29]  C. Eng,et al.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder , 2015, Neurotherapeutics.

[30]  Matthew W State,et al.  Autism spectrum disorders: from genes to neurobiology , 2015, Current Opinion in Neurobiology.

[31]  L. Mucke,et al.  Tau Reduction Diminishes Spatial Learning and Memory Deficits after Mild Repetitive Traumatic Brain Injury in Mice , 2014, PloS one.

[32]  E. Roberson,et al.  Seizure resistance without parkinsonism in aged mice after tau reduction , 2014, Neurobiology of Aging.

[33]  Paulin Jirkof,et al.  Burrowing and nest building behavior as indicators of well-being in mice , 2014, Journal of Neuroscience Methods.

[34]  L. Mucke,et al.  Tau Reduction Prevents Disease in a Mouse Model of Dravet Syndrome , 2014, Annals of neurology.

[35]  S. Imai,et al.  Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging , 2014, The EMBO journal.

[36]  C. Gross,et al.  Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders , 2014, Front. Mol. Neurosci..

[37]  J. Götz,et al.  Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus , 2013, PloS one.

[38]  K. Chadman,et al.  Water T-maze: A useful assay for determination of repetitive behaviors in mice , 2013, Journal of Neuroscience Methods.

[39]  Eunjoon Kim,et al.  Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses , 2013, Front. Mol. Neurosci..

[40]  D. Holtzman,et al.  Antisense Reduction of Tau in Adult Mice Protects against Seizures , 2013, The Journal of Neuroscience.

[41]  Meaghan Morris,et al.  Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice , 2013, Neurobiology of Aging.

[42]  J. Martinez-Agosto,et al.  Macrocephaly as a Clinical Indicator of Genetic Subtypes in Autism , 2013, Autism research : official journal of the International Society for Autism Research.

[43]  K. Yamakawa,et al.  Mouse with Nav1.1 haploinsufficiency, a model for Dravet syndrome, exhibits lowered sociability and learning impairment , 2013, Neurobiology of Disease.

[44]  S. Younkin,et al.  Tau Loss Attenuates Neuronal Network Hyperexcitability in Mouse and Drosophila Genetic Models of Epilepsy , 2013, The Journal of Neuroscience.

[45]  Michael E. Greenberg,et al.  Activity-dependent neuronal signalling and autism spectrum disorder , 2013, Nature.

[46]  D. Campion,et al.  Copy number variations involving the microtubule-associated protein tau in human diseases. , 2012, Biochemical Society transactions.

[47]  William A Catterall,et al.  Autistic behavior in Scn1a+/− mice and rescue by enhanced GABAergic transmission , 2012, Nature.

[48]  B. Zhang,et al.  Pentylenetetrazole‐induced seizures cause acute, but not chronic, mTOR pathway activation in rat , 2012, Epilepsia.

[49]  S. Spence,et al.  Common neurological co-morbidities in autism spectrum disorders , 2011, Current opinion in pediatrics.

[50]  D. Geschwind,et al.  Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits , 2011, Cell.

[51]  Xiao-Rong Liu,et al.  Autism in Dravet syndrome: Prevalence, features, and relationship to the clinical characteristics of epilepsy and mental retardation , 2011, Epilepsy & Behavior.

[52]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[53]  G. Feng,et al.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction , 2011, Nature.

[54]  D. Gutmann,et al.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. , 2011, Human molecular genetics.

[55]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[56]  M. Cuccaro,et al.  Autism and epilepsy: Historical perspective , 2010, Brain and Development.

[57]  Yunfei Huang,et al.  Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy , 2010, Neurobiology of Disease.

[58]  C. Lord,et al.  Behavioural phenotyping assays for mouse models of autism , 2010, Nature Reviews Neuroscience.

[59]  Cornelis J. Weijer,et al.  Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN , 2009, Oncogene.

[60]  T. Arendt,et al.  Pattern of tau isoforms expression during development in vivo , 2009, International Journal of Developmental Neuroscience.

[61]  P. Buckmaster,et al.  Inhibition of the Mammalian Target of Rapamycin Signaling Pathway Suppresses Dentate Granule Cell Axon Sprouting in a Rodent Model of Temporal Lobe Epilepsy , 2009, The Journal of Neuroscience.

[62]  L. Zeng,et al.  The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy , 2009, The Journal of Neuroscience.

[63]  Daniel H. Geschwind,et al.  Advances in autism. , 2009, Annual review of medicine.

[64]  Wei Zhang,et al.  Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice , 2009, The Journal of Neuroscience.

[65]  G. Schellenberg,et al.  Tau isoform regulation is region‐ and cell‐specific in mouse brain , 2008, The Journal of comparative neurology.

[66]  H. Lane,et al.  Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function , 2008, The Journal of Neuroscience.

[67]  D. Gutmann,et al.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex , 2008, Annals of neurology.

[68]  Hiroyuki Miyamoto,et al.  Nav1.1 Localizes to Axons of Parvalbumin-Positive Inhibitory Interneurons: A Circuit Basis for Epileptic Seizures in Mice Carrying an Scn1a Gene Mutation , 2007, The Journal of Neuroscience.

[69]  Jian-Zhi Wang,et al.  Effects of tau phosphorylation on proteasome activity , 2007, FEBS letters.

[70]  Wei Zhang,et al.  Pten Regulates Neuronal Arborization and Social Interaction in Mice , 2006, Neuron.

[71]  D. Stephan,et al.  Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. , 2006, The New England journal of medicine.

[72]  Søren Højsgaard,et al.  The R Package geepack for Generalized Estimating Equations , 2005 .

[73]  C Eng,et al.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations , 2005, Journal of Medical Genetics.

[74]  Rémi Quirion,et al.  Comparative signaling pathways of insulin‐like growth factor‐1 and brain‐derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival , 2004, Journal of neurochemistry.

[75]  Colin L. Stewart,et al.  Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1 , 2003, The Journal of cell biology.

[76]  H. McDermid,et al.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms , 2003, Journal of medical genetics.

[77]  L. Chandler,et al.  Activity‐dependent NMDA receptor‐mediated activation of protein kinase B/Akt in cortical neuronal cultures , 2002, Journal of neurochemistry.

[78]  L. Lagae,et al.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. , 2001, American journal of human genetics.

[79]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[80]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[81]  J. Brion,et al.  Developmental Changes in τ Phosphorylation: Fetal τ Is Transiently Phosphorylated in a Manner Similar to Paired Helical Filament‐τ Characteristic of Alzheimer's Disease , 1993, Journal of neurochemistry.

[82]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[83]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[84]  L. Cantley,et al.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.

[85]  M. Kirschner,et al.  Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes , 1984, The Journal of cell biology.

[86]  Morton B. Brown,et al.  Robust Tests for the Equality of Variances , 1974 .

[87]  L. Buée,et al.  Mutant huntingtin alters Tau phosphorylation and subcellular distribution. , 2015, Human molecular genetics.

[88]  Y. B. Wah,et al.  Power comparisons of Shapiro-Wilk , Kolmogorov-Smirnov , Lilliefors and Anderson-Darling tests , 2011 .

[89]  Thomas Bourgeron,et al.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.

[90]  Catherine Lord,et al.  Autism Spectrum Disorders , 2000, Neuron.